1 / 16

Platform downstream processes in the age of continuous chromatography: A case study

Platform downstream processes in the age of continuous chromatography: A case study. Mark Brower BioProcess Technology & Expression Bioprocess Development Kenilworth, NJ. Integrated Continuous Biomanufacturing Castelldefels , Spain 20-24 October 2013. Transition to Future Concepts.

akando
Télécharger la présentation

Platform downstream processes in the age of continuous chromatography: A case study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Platform downstream processes in the age of continuous chromatography: A case study Mark Brower BioProcess Technology & Expression Bioprocess Development Kenilworth, NJ Integrated Continuous Biomanufacturing Castelldefels, Spain 20-24 October 2013

  2. Transition to Future Concepts To meet increasing global demands requires… PROCESS INTENSIFICATION Batch Stainless Batch Stainless / Single Use Continuous Single Use Enabled Next Generation

  3. Primary Recovery (Centrifugation / MF + DF) Bulk Purification Protein A Chromatography Viral Inactivation (Low pH Hold) DNA / HCP / Viral Adsorption Anion Exchange Chromatography Variant and Aggregate Clearance Cation Exchange Chromatography Viral Filtration Nanofiltration Concentration / Buffer Exchange Microfiltration / Diafiltration Bioburden Reduction Sterile Filtration mAb Downstream Purification 6H Bulk 12H 18H 24H • Increased flexibility • Reduced footprint • Reduced capital spend • Better resource utilization 30H Fine 36H 42H 48H Formulation 54H 60H

  4. p p p p p p Continuous Processing Vision - 2,000L SUB* Formulation: BRF/DiaF Continuous UF A E X M Anion Exchange Membrane Surge Bag S U B* BRF p Viral Filtration Continuous Viral Inactivation p Single-Use Centrifugation Surge Bag Surge Bag Surge Bag Surge Bag Depth /BRF Filtration Polishing Step BioSMB Protein A BRF BRF Overall DSP Time Cycle is Dictated by the Longest Step Other Steps are Lengthened to Compensate *Single-Use Bioreactor

  5. Continuous Processing Case Study mAb 1- Non-platform AEX Membrane SMB Protein A SU Centrifuge Harvest Bag SPTFF SUB DF / BRF Viral Inactivation Mixed Mode

  6. C1 C2 C4 C3 Strip Elute Eq Wash 2 Product Waste Depleted Feed Wash 2nd pass 2nd pass Feed C6 C8 C5 C7 MCC for Bind & Elute Applications • Methods based on batch process • Loading, washing, elution, CIP carried out simultaneously • Flexibility in loading zone Switch Time

  7. CEX CMCC Load Zone Design Feed 2nd Pass Feed Longer residence time in the elution zone Similar column cycling compared with protein A Productivity 3.7X batch process 2nd Pass W1 W1 • 2 methods designed to maximize time in the elution zone • Wash 1 in parallel 8 columns (shorter / continuous feed) • Wash 1 in series 6 columns (longer / discontinuous feed)

  8. SMB Transformation of Platform CEX Step • 1.2cm x 3cm pre-packed columns • Poros HS Adsorbent • qbatch=50mg/mL • Feed = 11-13g/L • 2 different load zone configurations • Good agreement between experimental and theoretical capture efficiency • CMCC loading was 60-73mg/mL at high yield >95% 3.7 x Specific Productivity Design Equations* *Miyauchi and Vermeulen (1963)

  9. Aggregate Clearance – Wash in Series Configuration • Effect of column height investigated • 1.2 x 3.4cm, 1.2 x 6.8cm, 0.5 x 20cm • Feed aggregation varied (low and high) • Six 1.2 x 3.4cm columns for MCC • 4th cycle fractionation (20 fractions per column pooled) • Similar pre-peak observed in batch and MCC Process • Similar pool aggregate levels observed • Little difference observed at different column heights

  10. Integration of MCC CEX into Continuous DSP- 100L platform harvest p p p p p p Formulation: BRF/DiaF CRITICALITY pH Continuous UF Continuous UF A E X M Surge Bag S U B* BRF p Viral Filtration VI p Surge Bag Surge Bag Surge Bag Surge Bag Depth /BRF Filtration BioSMB CEX BioSMB Protein A BRF BRF

  11. Continuous CEX Performance Column • 16 Overlaid CEX Elution Profiles • AEXM Effluent Feed STDEV(%) Between Columns =1.01%

  12. Continuous Processing Case Study mAb 2- Platform Mass Balance = 93%

  13. DSP Productivity Enhancement • MCC steps enjoy a modest specific productivity increase • Other steps suffer from lower specific productivities because they are slowed to accommodate the incoming flow rate • The overall DSP will be 2-4x more productive (g/day) by operating in parallel (dependent on Protein A column sizing)

  14. Conclusions and Future Work • A platform cation exchange step was transformed into a MCC process • 3.6X specific productivity increase • Maintained consistent aggregate separation performance compared to the batch process • Integrated into continuous DSP top reflect platform operation with 84% yield at the 100L scale • Matched cycles with protein A step • Interface CEX step with continuous viral filtration • Scale up process to 2000L in 24hours

  15. Acknowledgements • BTE • Ying Hou • David Pollard • Analytical Support • Joe Fantuzzo • John Troisi • Jun Heo • Fermentation Support • Patty Rose • Chris Kistler • Rachel Bareither • Protein Purification Process Development • Nihal Tugcu • Thomas Linden • Marc Bisschops • Steve Allen

  16. Questions?

More Related